Travere Therapeutics, Inc. (TVTX)
45.11
+0.35
(+0.78%)
USD |
NASDAQ |
May 07, 10:40
Travere Therapeutics SG&A Expense (TTM) : 264.36M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ligand Pharmaceuticals, Inc. | 92.45M |
| Revolution Medicines, Inc. | 195.04M |
| ICU Medical, Inc. | 625.21M |
| Tandem Diabetes Care, Inc. | 444.99M |
| iRhythm Holdings, Inc. | 508.48M |